12/30/2024 7:07 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/16/2024 6:32 PM | Athyrium Funds GP Holdings LLC (Reporting) Athyrium Opportunities 2020 LP (Reporting) Athyrium Opportunities Associates Co-Invest LLC (Reporting) Athyrium Opportunities Associates III GP LLC (Reporting) Athyrium Opportunities Associates III LP (Reporting) Athyrium Opportunities III Acquisition 2 LP (Reporting) Athyrium Opportunities III Acquisition LP (Reporting) Athyrium Opportunities III Co-Invest 1 LP (Reporting) Biora Therapeutics (Issuer) Ferrell Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2024 6:00 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 9:01 AM | Biora Therapeutics (Subject) HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G | |
10/29/2024 3:43 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/29/2024 7:37 AM | Biora Therapeutics (Filer)
| Form 424B5 | |
10/29/2024 7:28 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
10/29/2024 7:15 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
10/29/2024 7:19 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
10/29/2024 7:21 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
10/29/2024 7:24 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
Get the Latest News and Ratings for BIOR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Biora Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
10/23/2024 4:24 PM | Biora Therapeutics (Filer)
| Form DEF 14A | |
10/11/2024 3:52 PM | Biora Therapeutics (Filer)
| Form PRE 14A | |
10/11/2024 7:00 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/09/2024 4:40 PM | Athyrium Opportunities III Co-Invest 1 LP (Filed by) Biora Therapeutics (Subject)
| Form SC 13D/A | |
09/16/2024 3:30 PM | Biora Therapeutics (Filer)
| Form DEF 14A | |
09/13/2024 9:37 AM | Athyrium Opportunities III Co-Invest 1 LP (Filed by) Biora Therapeutics (Subject)
| Form SC 13D/A | |
09/05/2024 5:02 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/03/2024 11:15 PM | Biora Therapeutics (Filer)
| Form EFFECT | |
09/03/2024 3:31 PM | Biora Therapeutics (Filer)
| Form PRE 14A | |
08/23/2024 4:06 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
08/23/2024 4:08 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
08/23/2024 4:11 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
08/23/2024 4:13 PM | Biora Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
08/23/2024 4:03 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
08/21/2024 4:00 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/20/2024 3:15 PM | Biora Therapeutics (Subject) DAVIDSON KEMPNER CAPITAL MANAGEMENT LP (Filed by)
| Form SC 13G | |
08/14/2024 8:57 PM | Athyrium Funds GP Holdings LLC (Reporting) Athyrium Opportunities 2020 LP (Reporting) Athyrium Opportunities Associates Co-Invest LLC (Reporting) Athyrium Opportunities Associates III GP LLC (Reporting) Athyrium Opportunities Associates III LP (Reporting) Athyrium Opportunities III Acquisition 2 LP (Reporting) Athyrium Opportunities III Acquisition LP (Reporting) Athyrium Opportunities III Co-Invest 1 LP (Reporting) Biora Therapeutics (Issuer) Ferrell Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 8:58 PM | Athyrium Opportunities III Co-Invest 1 LP (Filed by) Biora Therapeutics (Subject)
| Form SC 13D/A | |
08/12/2024 3:30 PM | Biora Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024 3:15 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/18/2024 7:05 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/08/2024 8:42 PM | Athyrium Opportunities III Co-Invest 1 LP (Filed by) Biora Therapeutics (Subject)
| Form SC 13D/A | |
07/08/2024 8:15 PM | Athyrium Funds GP Holdings LLC (Reporting) Athyrium Opportunities 2020 LP (Reporting) Athyrium Opportunities Associates Co-Invest LLC (Reporting) Athyrium Opportunities Associates III GP LLC (Reporting) Athyrium Opportunities Associates III LP (Reporting) Athyrium Opportunities III Acquisition 2 LP (Reporting) Athyrium Opportunities III Acquisition LP (Reporting) Athyrium Opportunities III Co-Invest 1 LP (Reporting) Biora Therapeutics (Issuer) Ferrell Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/05/2024 8:00 PM | Athyrium Funds GP Holdings LLC (Reporting) Athyrium Opportunities 2020 LP (Reporting) Athyrium Opportunities Associates Co-Invest LLC (Reporting) Athyrium Opportunities Associates III GP LLC (Reporting) Athyrium Opportunities Associates III LP (Reporting) Athyrium Opportunities III Acquisition 2 LP (Reporting) Athyrium Opportunities III Acquisition LP (Reporting) Athyrium Opportunities III Co-Invest 1 LP (Reporting) Biora Therapeutics (Issuer) Ferrell Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2024 7:21 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/01/2024 5:04 AM | Biora Therapeutics (Filer)
| Form 424B5 | |
07/01/2024 5:07 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/14/2024 3:30 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2024 6:31 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/06/2024 3:33 PM | Biora Therapeutics (Issuer) Howe Jill Ann (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
9/9 on TSLA from June to January (Ad) Please take a look at THIS case study on Target (TGT)
You’ll see exactly how the tool works to trade long and short, even when the markets seem to be predicting the exact opposite.
Now, this tool has been so accurate over recent months that I’m planning to send you 14 more real-world examples of winning trades that anyone using this tool could have captured.
And it’s all building to Monday, February 24 @ 1pm ET when I’ll bring the tool to the public for the first time and show you how you can put it on your own charts! Tap here to catch the TGT case study and learn more |
06/06/2024 3:33 PM | Biora Therapeutics (Issuer) Powell Lynne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 3:33 PM | Alter Jeffrey D. (Reporting) Biora Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 3:33 PM | Biora Therapeutics (Issuer) Kotzin Brian L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2024 11:15 PM | Biora Therapeutics (Filer)
| Form EFFECT | |
06/02/2024 11:15 PM | Biora Therapeutics (Filer)
| Form EFFECT | |
04/24/2024 3:06 PM | Biora Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024 3:11 PM | Biora Therapeutics (Filer)
| Form ARS | |
04/17/2024 11:15 PM | Biora Therapeutics (Filer)
| Form EFFECT | |
04/12/2024 3:30 PM | Biora Therapeutics (Filer)
| Form PRE 14A | |
04/02/2024 7:43 PM | Athyrium Opportunities 2020 LP (Filed by) Biora Therapeutics (Subject)
| Form SC 13D/A | |
04/02/2024 3:44 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
04/02/2024 3:46 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
04/02/2024 3:48 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/01/2024 3:45 PM | Biora Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/26/2024 3:10 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/20/2024 5:29 PM | Biora Therapeutics (Subject) Context Capital Management, LLC (Filed by)
| Form SCHEDULE 13G | |
03/11/2024 7:11 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |